Fig 5. Effect of CMBsαvβ3 in 5-FC / GCV—induced cell cycle arrest in HepG2 cells.
A. Cell cycle analysis of untreated HepG2 cells and HepG2 cells treated with 5-FC / GCV, 5-FC / GCV + ultrasound, or 5-FC / GCV + ultrasound + CMBsαvβ3for 24, 48 and 72 hours, as analyzed by flow cytometry and PI staining. Each histogram is representative of three experiments. B. The effects of 5-FC / GCV + ultrasound + CMBsαvβ3treatment on the cell cycle distribution of HepG2 cells were analyzed using Multicycle software program (Phoenix Flow System) (mean ± SD of three experiments; *p < 0.01).